All Stories

  1. A diagnostic algorithm for children presenting with peripheral facial nerve palsy and inconclusive diagnosis of neuroborreliosis
  2. Die Macht der Sprache
  3. Le pouvoir des mots
  4. Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia
  5. Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study
  6. Associations between salivary cytokines and oral health, age, and sex in healthy children
  7. Infektiologische Versorgung minderjähriger Flüchtlinge am Beispiel der Ukraine
  8. Dosing and Monitoring of Isoniazid in a Preterm, Extremely Low Birth Weight Infant After In Utero Exposure to Mycobacterium tuberculosis: A Case Study and Literature Review
  9. Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States
  10. Associations between salivary cytokines and oral health, age, and sex in healthy children
  11. Malaria in Refugee Children Resettled to a Holoendemic Area of Sub-Saharan Africa
  12. Paediatric refugees from Ukraine: guidance for health care providers
  13. Neonates with SARS-CoV-2 infection: spectrum of disease from a prospective nationwide observational cohort study
  14. Aktualisierte Empfehlungen zur infektiologischen Versorgung von Flüchtlingen im Kindes- und Jugendalter in Deutschland (Stand 30. März 2022), angemeldet als S1-Leitlinie (AWMF-Register Nr. 048-017)
  15. Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Post Hoc Analysis of a Randomized Controlled Trial
  16. Please stop the Russian-Ukrainian war – children will be more than grateful
  17. The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections
  18. Towards Accurate Point-of-Care Tests for Tuberculosis in Children
  19. Strengthening Tuberculosis Services for Children and Adolescents in Low Endemic Settings
  20. Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area
  21. Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study
  22. Apparent life-threatening events and brief resolved unexplained events: management of children at a Swiss tertiary care center
  23. Interseasonal RSV infections in Switzerland – rapid establishment of a clinician-led national reporting system (RSV EpiCH)
  24. Subclinical Tuberculosis in Children: Diagnostic Strategies for Identification Reported in a 6-year National Prospective Surveillance Study
  25. X-Linked Lymphoproliferative Disease Mimicking Multisystem Inflammatory Syndrome in Children—A Case Report
  26. Cytokines in saliva as biomarkers of oral and systemic oncological or infectious diseases: A systematic review
  27. 8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation
  28. 8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation
  29. Availability of fixed-dose, child-friendly formulations of first-line tuberculosis drugs in Europe
  30. Factors Associated With Hospital and Intensive Care Admission in Paediatric SARS-CoV-2 Infection: A Prospective Nationwide Observational Cohort Study
  31. Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany, Austria and Switzerland
  32. TB and COVID-19 in migrants – the need to focus on both conditions
  33. Correlation of Vaccine Responses
  34. HIV-Infected Patients Developing Tuberculosis Disease Show Early Changes in the Immune Response to Novel Mycobacterium tuberculosis Antigens
  35. Changes in pediatric infections during the COVID-19 pandemic: ‘a quarantrend for coronials’?
  36. Correction to: Preventing tuberculosis in paediatric kidney transplant recipients: is there a role for BCG immunisation pre-transplantation in low tuberculosis incidence countries?
  37. Machine Learning Algorithms Evaluate Immune Response to Novel Mycobacterium tuberculosis Antigens for Diagnosis of Tuberculosis
  38. Health care provided to recent asylum-seeking and non-asylum-seeking pediatric patients in 2016 and 2017 at a Swiss tertiary hospital - a retrospective study
  39. Pediatric Tuberculosis Disease during Years of High Refugee Arrivals: A 6-Year National Prospective Surveillance Study
  40. Mycobacterium ulcerans-specific immune response after immunisation with bacillus Calmette-Guérin (BCG) vaccine
  41. Additional Concerns Regarding Children With Coronavirus Disease 2019
  42. Preventing tuberculosis in paediatric kidney transplant recipients: is there a role for BCG immunisation pre-transplantation in low tuberculosis incidence countries?
  43. Long-Term Outcomes of Acute Osteoarticular Infections in Children
  44. Characterising the epidemic spread of influenza A/H3N2 within a city through phylogenetics
  45. Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects
  46. Asylum-Seeking Children with Medical Complexity and Rare Diseases in a Tertiary Hospital in Switzerland
  47. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study
  48. Intermediate monocytes exhibit higher levels of TLR2, TLR4 and CD64 early after congenital heart surgery
  49. Swiss consensus recommendations on urinary tract infections in children
  50. COVID-19 in children: patiently and critically evaluate the scientific evidence
  51. Reasons for admission in asylum-seeking and non-asylum-seeking patients in a paediatric tertiary care centre
  52. Age-dependent response of the human nasal epithelium to rhinovirus infection
  53. Preventable admissions and emergency-department-visits in pediatric asylum-seeking and non-asylum-seeking patients
  54. Characterising the epidemic spread of Influenza A/H3N2 within a city through phylogenetics
  55. The global COVID-19 response must include refugees and migrants
  56. High-resolution influenza mapping of a city reveals socioeconomic determinants of transmission within and between urban quarters
  57. In Reference to The Management of Nontuberculous Mycobacterial Cervicofacial Lymphadenitis: A View Beyond Surgery
  58. Tuberculosis Disease in Children and Adolescents on Therapy With Antitumor Necrosis Factor-ɑ Agents: A Collaborative, Multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) Study
  59. Biological sex influences antibody responses to routine vaccinations in the first year of life
  60. Perspective of asylum-seeking caregivers on the quality of care provided by a Swiss paediatric hospital: a qualitative study
  61. Identification of influenza urban transmission patterns by geographical, epidemiological and whole genome sequencing data: protocol for an observational study
  62. The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses
  63. Medical care for migrant children in Europe: a practical recommendation for first and follow-up appointments
  64. A systematic literature review of reported challenges in health care delivery to migrants and refugees in high-income countries - the 3C model
  65. Mycoplasma pneumoniae detection in children with respiratory tract infections and influence on management–a retrospective cohort study in Switzerland
  66. Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children—A Systematic Review and Meta-Analysis
  67. Tuberculosis screening in migrant children in Switzerland.
  68. The influence of neonatal Bacille Calmette-Guérin (BCG) immunisation on heterologous vaccine responses in infants
  69. Mycobacteria-Specific Mono- and Polyfunctional CD4+ T Cell Profiles in Children With Latent and Active Tuberculosis: A Prospective Proof-of-Concept Study
  70. Immunologic-based Diagnosis of Latent Tuberculosis Among Children Younger Than 5 Years of Age Exposed and Unexposed to Tuberculosis in Tanzania
  71. African Tick-Bite Fever
  72. Clinical impact of the type VI secretion system on virulence of Campylobacter species during infection
  73. Cytokine kinetic profiles in children with acute lower respiratory tract infection: a post hoc descriptive analysis from a randomized control trial
  74. A Systematic Review on Novel Mycobacterium tuberculosis Antigens and Their Discriminatory Potential for the Diagnosis of Latent and Active Tuberculosis
  75. Double trouble: visceral leishmaniasis in twins after traveling to Tuscany – a case report
  76. Cost-Effectiveness of Tuberculosis Screening for Migrant Children in Low-Incidence countries
  77. Evaluation of the current use of imaging modalities and pathogen detection in children with acute osteomyelitis and septic arthritis
  78. Use of Xpert MTB/RIF Ultra assays among paediatric tuberculosis experts in Europe
  79. Alveolar echinococcosis in the liver of an adolescent boy
  80. The Immunomodulatory Effects of Macrolides—A Systematic Review of the Underlying Mechanisms
  81. Influence of Age and Other Factors on Cytokine Expression Profiles in Healthy Children—A Systematic Review
  82. Cytokine profiling in healthy children shows association of age with cytokine concentrations
  83. Towards better healthcare for migrant and refugee children in Europe
  84. S2k-Leitlinie zur Diagnostik, Prävention und Therapie der Tuberkulose im Kindes- und Jugendalter
  85. The spectrum of care for pediatric refugees and asylum seekers at a tertiary health care facility in Switzerland in 2015
  86. Drivers of antibiotic prescribing in children and adolescents with febrile lower respiratory tract infections
  87. Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections
  88. Kawasaki disease: what the paediatrician needs to know
  89. The impact of Bacille Calmette-Guérin shortage on immunisation practice and policies in Europe – A Paediatric Tuberculosis Network European Trials Group (ptbnet) survey
  90. A personalised approach is needed for the management of non-tuberculous mycobacterial cervicofacial lymphadenitis
  91. European shortage of purified protein derivative and its impact on tuberculosis screening practices
  92. Group A Streptococcal Suppurative Arthritis and Osteomyelitis of the Shoulder With Brachial Plexus Palsy in a Newborn
  93. Chikungunya Fever During Pregnancy and in Children: An Overview on Clinical and Research Perspectives
  94. Odontoid Osteomyelitis in Children
  95. Comparable CD4 and CD8 T cell responses and cytokine release after at-birth and delayed BCG immunisation in infants born in Australia
  96. Buccal Fat Pad Herniation in an Infant
  97. Therapeutic Drug Monitoring for Anti-infective Agents in Pediatrics
  98. Nontuberculous Mycobacterial Disease in Children – Epidemiology, Diagnosis & Management at a Tertiary Center
  99. Erratum zu: Tuberkulosescreening bei asylsuchenden Kindern und Jugendlichen ≺ 15 Jahren in Deutschland
  100. Tuberculosis in young refugees
  101. Tuberkulosescreening bei asylsuchenden Kindern und Jugendlichen ‹ 15 Jahren in Deutschland
  102. Current status of Bacille Calmette Guérin (BCG) immunisation in Europe – A ptbnet survey and review of current guidelines
  103. Diagnostic Tests for Childhood Tuberculosis
  104. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis
  105. The Swiss National Registry for Primary Immunodeficiencies: report on the first 6 years’ activity from 2008 to 2014
  106. Meropenem-associated severe neutropenia in an infant with brain abscess
  107. Chikungunya in Children
  108. The management of non-tuberculous cervicofacial lymphadenitis in children: A systematic review and meta-analysis
  109. Bullous Rash in an Adolescent Girl
  110. Actinomyces neuiiIsolated From a 20-Month-Old Girl With Cervical Lymphadenitis
  111. Novel concepts in the epidemiology, diagnosis and prevention of childhood tuberculosis
  112. Question 1: Should newborns of mothers with isolated antibodies to hepatitis B core antigen be immunised?
  113. Availability and Use of Molecular Microbiological and Immunological Tests for the Diagnosis of Tuberculosis in Europe
  114. Aerococcus urinae: a possible reason for malodorous urine in otherwise healthy children
  115. Tuberkulose im Kindesalter
  116. Infants born in Australia to mothers from countries with a high prevalence of tuberculosis: to BCG or not to BCG?
  117. Epidemiology of childhood tuberculosis in Switzerland between 1996 and 2011
  118. The Contribution of Non-Conventional T Cells and NK Cells in the Mycobacterial-Specific IFNγ Response in Bacille Calmette-Guérin (BCG)-Immunized Infants
  119. Infants born in Australia to mothers from countries with a high prevalence of tuberculosis: to BCG or not to BCG?
  120. Positive Linking
  121. Non-specific effect of Bacille Calmette-Guérin vaccine on the immune response to routine immunisations
  122. To x-ray or not to x-ray? Screening asymptomatic children for pulmonary TB: a retrospective audit
  123. Reply: Bacille Calmette-Guérin Vaccine: Innate Immunity and Nonspecific Effects
  124. Infections in Children Treated With Biological Agents
  125. Fieber ohne Fokus und Fieber unklarer Ursache im Kindesalter
  126. Infektionen
  127. Inclusion of latent tuberculosis infection as a separate entity into the international classification of diseases
  128. Interferon-  release assays for the diagnosis of tuberculosis in children
  129. Actinobaculum schaalii an emerging pediatric pathogen?
  130. A Comparative Analysis of Polyfunctional T Cells and Secreted Cytokines Induced by Bacille Calmette-Guérin Immunisation in Children and Adults
  131. The Role of Panton-Valentine Leukocidin in Staphylococcus aureus Musculoskeletal Infections in Children
  132. To TST or not to TST: Is tuberculin skin testing necessary before BCG immunisation in children?
  133. The Influence of Bacille Calmette-Guérin Vaccine Strain on the Immune Response against Tuberculosis
  134. The Age-Related Risk of Co-Existing Meningitis in Children with Urinary Tract Infection
  135. Absence of interferon-gamma release assay conversion following tuberculin skin testing
  136. Tuberculous dactylitis—an easily missed diagnosis
  137. The potential danger of a solely interferon-  release assay-based approach to testing for latent Mycobacterium tuberculosis infection in children
  138. Lessons Learned From an Unusual Presentation of CD3+, CD56− T-Cell Large Granular Lymphocyte Leukemia
  139. Mycobacterium marinum infection following kayaking injury
  140. Perception, attitudes and knowledge regarding the 2009 swine‐origin influenza A (H1N1) virus pandemic among health‐care workers in Australia
  141. Discordance between TSTs and IFN-  release assays: the role of NTM and the relevance of mycobacterial sensitins
  142. Indeterminate Interferon-γ Release Assay Results in Children
  143. Too much of a good thing: Management of BCG vaccine overdose
  144. Interferon-γ Release Assays for the Diagnosis of Tuberculosis
  145. Monkey Bites in Travelers
  146. Mapping the global use of different BCG vaccine strains
  147. A 2 year old girl with fever, cough, and tachypnoea
  148. Human Immunodeficiency Virus-Infected Boy With Stevens-Johnson Syndrome Caused by Nevirapine
  149. To BCG or not to BCG?
  150. Susceptibility of Mycobacterium bovis BCG Vaccine Strains to Antituberculous Antibiotics
  151. Influence of BCG vaccine strain on the immune response and protection against tuberculosis
  152. A Three-Way Comparison of Tuberculin Skin Testing, QuantiFERON-TB Gold and T-SPOT.TB in Children
  153. What the Paediatrician Needs to Know When Pandemic Influenza Arrives in Clinical Practice
  154. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis
  155. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis
  156. Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child